Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Technologies Ovation RNA Amplification System and Agencourt s RNAPrep Kit and RNA Clean

Premium

NuGen Technologies said this week that it has launched the Ovation RNA amplification system.

According to the company, the system allows for the analysis of small RNA samples for gene expression experiments, especially those based on real-time quantitative PCR.

“Use of the system prior to QPCR analysis amplifies mRNA in potentially limited, biologically important samples such as small biopsies or flow sorted cells,” said NuGen, adding that “the end product of the protocol is cDNA, which can be directly measured by QPCR, thus eliminating the need for the traditional reverse transcriptase step.”


Agencourt has recently announced the expansion of its reagent products line to include the RNAPrep kit for RNA isolation and purification.

According to the company, the kit is optimized for isolating total RNA from eukaryotic cultured cells, and has been formatted to work in single tube through fully automated plate formats with streamlined processing times of under 20 minutes.

The RNAPrep is the second RNA-based product Agencourt has released this year, the company said. Previously, it introduced RNAClean, a purification kit designed for in vitro cDNA and RNA clean up.

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.